[go: up one dir, main page]

NO20055393L - Oralt desintegrerende tabletter - Google Patents

Oralt desintegrerende tabletter

Info

Publication number
NO20055393L
NO20055393L NO20055393A NO20055393A NO20055393L NO 20055393 L NO20055393 L NO 20055393L NO 20055393 A NO20055393 A NO 20055393A NO 20055393 A NO20055393 A NO 20055393A NO 20055393 L NO20055393 L NO 20055393L
Authority
NO
Norway
Prior art keywords
orally disintegrating
disintegrating tablets
microcrystalline cellulose
tablet
effective amount
Prior art date
Application number
NO20055393A
Other languages
English (en)
Other versions
NO20055393D0 (no
Inventor
Johannes Jan Platteeuw
Dennie Johan Marijn Van Heuvel
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20055393D0 publication Critical patent/NO20055393D0/no
Publication of NO20055393L publication Critical patent/NO20055393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Silisifisert mikrokrystallinsk cellulose anvendes for å tilveiebringe en tablett med oral desintegrasjon. Tabletten inneholder minst 30 % av den sihsifiserte mikrokrystallinske cellulosen og en effektiv mengde av et farmasøytisk aktiv middel.
NO20055393A 2003-04-16 2005-11-15 Oralt desintegrerende tabletter NO20055393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46302703P 2003-04-16 2003-04-16
PCT/EP2004/004119 WO2004091585A1 (en) 2003-04-16 2004-04-16 Orally disintegrating tablets

Publications (2)

Publication Number Publication Date
NO20055393D0 NO20055393D0 (no) 2005-11-15
NO20055393L true NO20055393L (no) 2006-01-16

Family

ID=33300032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055393A NO20055393L (no) 2003-04-16 2005-11-15 Oralt desintegrerende tabletter

Country Status (10)

Country Link
US (1) US20040265375A1 (no)
EP (1) EP1613289A1 (no)
JP (1) JP2006524650A (no)
CN (1) CN1787811A (no)
AU (1) AU2004229177A1 (no)
CA (1) CA2522100A1 (no)
NO (1) NO20055393L (no)
NZ (1) NZ542925A (no)
WO (1) WO2004091585A1 (no)
ZA (1) ZA200508361B (no)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
PT1243262E (pt) 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica
DE60100055T2 (de) 2001-03-21 2003-07-24 Schwarz Pharma Ag Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
CN1863517B (zh) * 2003-10-07 2011-08-03 安壮奇制药公司 快速崩解制剂
IL174758A (en) * 2003-10-10 2012-09-24 Synthon Bv Crystalline form of montelukast, pharmaceutical composition comprising it, process for the preparation thereof and uses thereof as a medicament
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
EP1709053B1 (en) * 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
KR20130006523A (ko) 2004-02-17 2013-01-16 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
US7501517B2 (en) * 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
DE102004028940A1 (de) * 2004-06-15 2006-01-12 Krka Tovarna Zdravil, D.D. Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
PL1781276T3 (pl) 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
US20060078615A1 (en) * 2004-10-12 2006-04-13 Boehringer Ingelheim International Gmbh Bilayer tablet of telmisartan and simvastatin
EP2283811A1 (en) 2004-10-19 2011-02-16 Krka Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising donepezil hydrochloride
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
RU2391115C2 (ru) * 2004-12-13 2010-06-10 МакНЕЙЛ-ППС, ИНК. Композиции и способы стабилизации активных фармацевтических ингредиентов
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
CZ200563A3 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
WO2006115770A2 (en) * 2005-04-22 2006-11-02 Teva Pharmaceuticals Usa, Inc. Orally disintegrating pharmaceutical tablet formulations of olanzapine
BRPI0609984A2 (pt) 2005-05-25 2010-05-18 Transcept Pharmaceuticals Inc uso de zolpidem ou um sal do mesmo
ZA200710205B (en) * 2005-05-25 2009-03-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
WO2007002518A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
JP2007015966A (ja) * 2005-07-06 2007-01-25 Fujimoto Corporation:Kk 口腔内崩壊錠
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
JP5241681B2 (ja) * 2005-08-01 2013-07-17 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
JP4439499B2 (ja) * 2005-08-01 2010-03-24 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
EP1923074A4 (en) * 2005-08-10 2011-09-14 Shionogi & Co TABLET WHICH CAN BE ORALLY DISINTEGRATED
WO2007020080A1 (en) * 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
FR2891147B1 (fr) * 2005-09-28 2007-12-07 Ethypharm Sa Comprimes orodispersibles de principes actifs amers
US20070093471A1 (en) * 2005-10-26 2007-04-26 Alamo Pharmaceuticals, Llc Compositions and methods for the administration clozapine formulations which modulate body weight
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
KR101345468B1 (ko) * 2005-11-18 2013-12-30 신톤 비.브이. 졸피뎀 정제
AR057909A1 (es) * 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
DE102005060377A1 (de) 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
CA2630235A1 (en) * 2005-12-20 2007-07-12 Teva Pharmaceutical Industries Ltd. Lansoprazole orally disintegrating tablets
US20100034887A1 (en) * 2005-12-23 2010-02-11 Lek Pharmaceuticals D.D. Bursting Pellets
EP1976522B2 (en) † 2005-12-30 2019-07-03 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition containing montelukast
ZA200806496B (en) * 2006-01-27 2009-12-30 Eurand Inc Drug delivery systems comprising weakly basic drugs and organic acids
US20070190145A1 (en) * 2006-01-27 2007-08-16 Eurand, Inc. Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
EP1815857A1 (en) * 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
EP1996552A1 (en) * 2006-03-17 2008-12-03 Synthon B.V. Montelukast amantadine salt
SG170766A1 (en) * 2006-03-24 2011-05-30 Kowa Co Oral fast-disintegrating tablet
WO2007134845A2 (en) * 2006-05-18 2007-11-29 Synthon B.V. Olanzapine pharmaceutical composition
US20070281014A1 (en) * 2006-06-01 2007-12-06 Cima Labs, Inc. Prednisolone salt formulations
US8637076B2 (en) * 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
PL2462990T3 (pl) 2006-06-15 2014-05-30 Ucb Pharma Gmbh Kompozycja farmaceutyczna obejmująca lakozamid i lewetyracetam o synergistycznym działaniu przeciwdrgawkowym
EP2040676A2 (en) * 2006-07-06 2009-04-01 Forest Laboratories, Inc. Orally dissolving formulations of memantine
JP2008044870A (ja) * 2006-08-11 2008-02-28 Elmed Eisai Kk 医薬組成物及びその製造方法
US20080138409A1 (en) * 2006-09-29 2008-06-12 Osinga Niels J Olanzapine pharmaceutical composition
BRMU8602968U (pt) * 2006-11-16 2008-09-30 Jr Walter Santos medicamento "ramipril + metformina" em forma combinada para doenças cardiovasculares
WO2008058355A2 (en) * 2006-11-16 2008-05-22 Walter Santos Junior Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases
GB2444904B (en) * 2006-12-05 2008-11-05 Michael Hilary Burke A Process For The Preparation of an Orally Administrable Unit Dose Tablet
JP5275815B2 (ja) * 2006-12-26 2013-08-28 塩野義製薬株式会社 リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
CA2721133C (en) 2007-04-13 2018-11-06 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations and methods of making and using the same
EP1997480A1 (en) * 2007-06-01 2008-12-03 The Jordanian Pharmaceutical Manufacturing Co. Mineral-fiber solid dispersion, method for preparing the same and use thereof as pharmaceutical tableting aid
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
EP2218443B1 (en) * 2007-11-21 2014-03-26 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablet
MX2010005175A (es) * 2007-12-08 2010-08-02 Bayer Schering Pharma Ag Comprimido dispersable oral.
JP2009196940A (ja) * 2008-02-22 2009-09-03 Takada Seiyaku Kk 口腔内速崩壊錠及びその製造法
EP2276739A1 (en) * 2008-04-25 2011-01-26 Synthon B.V. Process for making montelukast intermediates
US20100016265A1 (en) * 2008-07-16 2010-01-21 Qaiser Yusuf Anti-inflammatory composition and method for preparation
CN101766605B (zh) * 2008-12-29 2014-02-19 北京德众万全药物技术开发有限公司 包含普拉克索的可在口中分散的药物组合物
EP2410995A1 (en) 2009-03-26 2012-02-01 Royal College of Surgeons in Ireland Orodispersible tablets
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
US20120214820A1 (en) * 2009-09-15 2012-08-23 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
CA2940931C (en) 2009-10-01 2019-04-30 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
TR200907554A1 (tr) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.
CN102058549B (zh) * 2009-11-17 2014-08-27 北京万全阳光医学技术有限公司 一种含非那雄胺的口腔崩解片及其制备方法
CN101716151B (zh) * 2009-12-24 2012-06-27 杭州康恩贝制药有限公司 一种快速溶出的非那雄胺口服片剂及制备方法
EP2524689B1 (en) * 2009-12-28 2016-10-05 Nipro Corporation Method for producing donepezil tablets
JP2011213695A (ja) * 2010-04-02 2011-10-27 Taisho Pharm Ind Ltd ドネペジル塩酸塩含有口腔内速崩壊錠
WO2012003987A1 (en) * 2010-07-08 2012-01-12 Ratiopharm Gmbh Oral dosage form of deferasirox
AU2010363329A1 (en) * 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
EP2468254A1 (en) * 2010-12-15 2012-06-27 Hexal AG Orally disintegrating tablet having a taste masking effect
CN102727452B (zh) * 2011-04-01 2014-12-24 成都康弘药业集团股份有限公司 一种含右佐匹克隆的颗粒及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
JP6062693B2 (ja) * 2012-09-14 2017-01-18 沢井製薬株式会社 オランザピン含有製剤
US9597291B2 (en) * 2012-12-11 2017-03-21 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Orally disintegrating tablet containing asenapine
EP2964243B1 (en) 2013-03-06 2022-11-23 Capsugel Belgium NV Curcumin solid lipid particles and methods for their preparation and use
EP2826465B1 (en) * 2013-07-19 2018-09-05 Sanovel Ilac Sanayi ve Ticaret A.S. Orally disintegrating tablet formulations of donepezil
WO2015034678A2 (en) * 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
WO2015077535A2 (en) * 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases
CN104784047B (zh) * 2014-01-16 2018-09-21 南京瑞尔医药有限公司 一种非那雄胺组合物
CN105012253A (zh) * 2014-04-24 2015-11-04 南京长澳医药科技有限公司 一种盐酸普拉克索口腔崩解片及其制备方法
US20170112762A1 (en) * 2014-06-10 2017-04-27 Capsugel Belgium Nv Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
CN104027319A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 一种塞来昔布分散片及其制备方法
BR112017005362A2 (pt) 2014-09-17 2018-01-23 Steerlife India Private Ltd composição, forma de dosagem sólida oral, processo para preparação de grânulos efervescentes porosos, processador de parafuso duplo, e, grânulos efervescentes porosos.
JP2016079120A (ja) * 2014-10-15 2016-05-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 包装により安定性が改善されたオランザピン製剤
CN104382895A (zh) * 2014-10-22 2015-03-04 湖南明瑞制药有限公司 一种辛伐他汀组合物
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
US11324699B2 (en) 2014-12-04 2022-05-10 Capsugel Belgium Nv Lipid multiparticulate formulations
JP6513702B2 (ja) * 2014-12-25 2019-05-15 株式会社ダイセル 超速崩壊錠剤及びその製造方法
CN104771761A (zh) * 2015-03-19 2015-07-15 深圳国源国药有限公司 一种创新药用辅料硅化微晶纤维素及其制备方法
CN105147627B (zh) * 2015-08-19 2019-04-12 天津红日药业股份有限公司 一种含有盐酸普拉克索的药物组合物及其制备方法
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
RU2619213C1 (ru) * 2016-01-25 2017-05-12 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма зафирлукаста немедленного высвобождения и способ ее получения
US11110035B1 (en) 2016-02-05 2021-09-07 Gram Tactical Llc Tactical medicine dispensers
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CN108938580B (zh) * 2017-05-26 2022-09-27 万全万特制药江苏有限公司 盐酸帕罗西汀口崩片
CN109864975B (zh) * 2017-12-04 2021-10-08 成都康弘药业集团股份有限公司 一种阿立哌唑的口腔崩解片及其制备方法
WO2019175100A1 (en) * 2018-03-11 2019-09-19 Nanologica Ab Porous silica particles for use in compressed pharmaceutical dosage form
CN110840850B (zh) * 2018-07-24 2023-03-17 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
WO2020049505A1 (en) 2018-09-06 2020-03-12 Innopharmascreen Inc. Methods and compositions for treatment of asthma or parkinson's disease
JP7219979B2 (ja) * 2020-02-26 2023-02-09 日新製薬株式会社 被覆層を有する口腔内崩壊錠

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US50312A (en) * 1865-10-03 Improvement in handle attachments to small-arms
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) * 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
ES2274625T3 (es) * 1998-05-18 2007-05-16 Takeda Pharmaceutical Company Limited Comprimidos desintegrables en la boca que comprenden un bencimidazol.
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
BR0016482A (pt) * 1999-12-06 2002-12-24 Mendell Co Inc Edward Método para melhorar a compressibilidade de um superdesintegrante, obter um complexo de preparado de droga superdesintegrante altamente compatìvel , superdesintegrante aumentado e sua forma de dosagem sólida
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
AU2002355624B2 (en) * 2001-07-31 2006-02-02 H. Lundbeck A/S Crystalline composition containing escitalopram
EP1469829B1 (en) * 2002-02-01 2016-01-27 Bend Research, Inc Immediate release dosage forms containing solid drug dispersions
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete

Also Published As

Publication number Publication date
AU2004229177A1 (en) 2004-10-28
JP2006524650A (ja) 2006-11-02
EP1613289A1 (en) 2006-01-11
NO20055393D0 (no) 2005-11-15
CN1787811A (zh) 2006-06-14
ZA200508361B (en) 2006-12-27
NZ542925A (en) 2007-04-27
CA2522100A1 (en) 2004-10-28
US20040265375A1 (en) 2004-12-30
WO2004091585A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
NO20055393L (no) Oralt desintegrerende tabletter
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
NO20081843L (no) Farmasoytisk sammensetning for forbedret kognitiv funksjon
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
HUP0003186A2 (hu) Gyorsan széteső metil-cellulóz tabletták
TW200633730A (en) Oral disintegrating dosage forms
TR200002207T1 (tr) Slekoksib bileşikleri.
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
HUP0002316A2 (hu) Gyorsan olvadó orális adagolási formák
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
DE69838300D1 (de) Pharmazeutische suspensionstabletten-zusammenstellungen
AR053440A2 (es) Uso de una forma de dosificacion farmaceutica de liberacion sostenida para la manufactura de un medicamento, dicha forma de dosificacion farmaceutica y una tableta comprimida
RU2010128019A (ru) Пероральная диспергируемая таблетка
CO5070643A1 (es) Formulacion en tabletas comprimidas
HUP0102676A2 (hu) Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények
AP2004002999A0 (en) Organoleptically acceptable intraorally disintegrating compositions
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
DE602004004782D1 (de) Schnell wasserdispergierbare und Domperidon enthaltende Tabletten
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application